Arthur Ernest Schwarting
Affiliations: | 1949-1980 | Pharmacy | University of Connecticut, Storrs, CT, United States |
Area:
PharmacognosyGoogle:
"Arthur Ernest Schwarting"Bio:
(1917 - 1996)
http://www.pharmacognosy.us/wp-content/uploads/Arthur-Schwarting.pdf
http://documentslide.com/documents/the-academic-genealogy-of-arthur-e-schwarting-pharmacognosist.html
Mean distance: (not calculated yet)
Parents
Sign in to add mentorLovell David Hiner | grad student | 1943 | Ohio State | |
(A study of domestic ergot of wheat and rye.) |
Children
Sign in to add traineeAra Garo Paul | grad student | 1957 | University of Connecticut |
John Paul N. Rosazza | grad student | 1969 | University of Connecticut (Microtree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rosazza J, Bobbitt JM, Schwarting AE. (1970) Synthetic approaches to some of the Lythraceae alkaloids The Journal of Organic Chemistry. 35: 2564-2568 |
Paul AG, Scully NJ, Schwarting AE. (1960) The Biosynthesis of C14-Labeled Ergot Alkaloids* Journal of the American Pharmaceutical Association. 49: 14-16 |
CAREW DP, SCHWARTING AE. (1959) The infection of rye callus with Claviceps purpurea. Journal of the American Pharmaceutical Association. American Pharmaceutical Association. 48: 499-500 |
PAUL AG, SCHWARTING AE. (1955) C14-labeled ergot alkaloids. Science (New York, N.Y.). 121: 215 |
TYLER VE, SCHWARTING AE. (1954) The culture of Claviceps purpurea. III. Tryptophan metabolism. Journal of the American Pharmaceutical Association. American Pharmaceutical Association. 43: 207-11 |
PAUL AG, KELLEHER WJ, SCHWARTING AE. (1954) The culture of Claviceps purpurea. II. Preliminary metabolism studies. Journal of the American Pharmaceutical Association. American Pharmaceutical Association. 43: 205-7 |
TYLER VE, SCHWARTING AE. (1952) The culture of Claviceps purpurea. I. Growth and nutrition in submerged culture. Journal of the American Pharmaceutical Association. American Pharmaceutical Association. 41: 590-4 |